Brief: Spago Q1 Loss SEK 14.4 Million
May 9 (Reuters) - Spago Nanomedical AB (publ)
SPAGO.ST :
* Q1 NET SALES SEK 88,000 VERSUS SEK 0.2 MILLION YEAR AGO
* Q1 LOSS SEK 14.4 MILLION VERSUS LOSS SEK 9.9 MILLION YEAR
AGO
Source text for Eikon: ID:nMFN4GSdd6
Further company coverage: SPAGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose